Is Moderna Stock A Sell After Crumbling On Updated RSV Vaccine Results?Investors Business Daily • 07/10/24
Moderna to Report Second Quarter 2024 Financial Results on Thursday, August 1, 2024Accesswire • 07/10/24
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Moderna, Inc. - MRNAGlobeNewsWire • 07/07/24
Moderna Receives Project Award through BARDA's Rapid Response Partnership Vehicle Consortium to Accelerate Development of mRNA-based Pandemic Influenza VaccineAccesswire • 07/02/24
Investors Who Lost Money on Moderna, Inc. Should Contact Levi & Korsinsky About an Ongoing Investigation - MRNAAccesswire • 07/01/24
An Investigation Has Commenced on Behalf of Moderna, Inc. Shareholders. Contact Levi & Korsinsky to Discuss your MRNA LossesAccesswire • 06/28/24
EMA Committee For Medicinal Products For Human Use Adopts Positive Opinion Recommending Marketing Authorization Of Moderna's RSV Vaccine, mRESVIA(R)Accesswire • 06/28/24